Search

Your search keyword '"Kanekiyo, Takahisa"' showing total 474 results

Search Constraints

Start Over You searched for: Author "Kanekiyo, Takahisa" Remove constraint Author: "Kanekiyo, Takahisa"
474 results on '"Kanekiyo, Takahisa"'

Search Results

1. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.

2. Neurodevelopmental disorders modeling using isogeometric analysis, dynamic domain expansion and local refinement

4. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction

5. Author Correction: Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice

6. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

11. ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling

15. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins

16. Metabolome-wide association study on ABCA7 indicates a role of ceramide metabolism in Alzheimer’s disease

17. Author Correction: Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance

18. Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function

21. LRP1 is a neuronal receptor for α-synuclein uptake and spread

22. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids

23. Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitroand In Vivoin Mice

24. Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids

26. Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways

29. CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly

31. Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease

32. Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice

33. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease

34. Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

35. Relationships between PET and blood plasma biomarkers in corticobasal syndrome.

36. ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism

37. Gliovascular molecular alterations in Alzheimer’s disease: a cross‐tissue, cross‐species study

39. DNA methylation clustered by predicted chromatin state reveals distinct association patterns with neuropathologic and biochemical measures in the AD brain

43. APOE4-mediated amyloid-[beta] pathology depends on its neuronal receptor LRP1

49. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

50. A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models

Catalog

Books, media, physical & digital resources